Studies have shown that the DHT-dependent prostatic enlargement in human BPH is due to the unbalance of downstream paracrine regulators KGF, EGF, and IGFs, which drive the proliferation of epithelial cells, and TGF-β that promotes cell death [5]. The gene discussed is EGF; the disease is benign prostatic hyperplasia.